LipoScience Inc (NASDAQ:LPDX)
| 5.79 Data as of May 17 |  +0.20 / +3.58%Today’s Change | 5.55 Today|||52-Week Range 11.84 | -- Year-to-Date |
Latest LPDX News | Press Releases
No recent news for LipoScience Inc.
Today’s Trading
| Previous close | 5.59 |
| Today’s open | 5.64 |
| Day’s range | 5.56 - 5.89 |
| Volume | 233,389 |
| Average volume (3 months) | 63,082 |
| Market cap | $85.0M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -648.03% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +19.63% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TTHITransition Therapeut... | +0.02 | +0.69% |
| GALTGalectin Therapeutic... | +0.18 | +4.27% |
| PATHNupathe Inc | +0.05 | +1.59% |
| TROVTrovagene Inc | +0.71 | +11.87% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $54.8M |
| Annual profit (last year) | $246.0K |
| Net profit margin | 0.45% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Richard O. Brajer, MBA |
Chief Operating Officer Timothy J. Fischer |
Corporate headquarters Raleigh, North Carolina |
Forecasts
